These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9225949)

  • 21. Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.
    Gamelin E; Delva R; Jacob J; Merrouche Y; Raoul JL; Pezet D; Dorval E; Piot G; Morel A; Boisdron-Celle M
    J Clin Oncol; 2008 May; 26(13):2099-105. PubMed ID: 18445839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of recurrent breast cancer causing malignant pericardial effusion successfully managed with instillations of cisplatin].
    Sugimoto T; Kobayashi M; Okabayashi T; Hokimoto N; Nishimori H; Yamasaki F; Moriki T; Takahashi T; Sasaguri S; Araki K
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1311-3. PubMed ID: 16184930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
    Maurer U; Härle M; Jungius KP
    Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of recurring breast cancer causing pericardial metastasis showing a good response following local treatment with methotrexate].
    Nakaguchi K; Furukawa J; Maruyama N; Nakamura M; Shingai T; Maruyama K; Katsumoto Y; Okajima S; Sue F; Yoshiwara W
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1753-6. PubMed ID: 11708026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Danesi R; Vannozzi F; Falcone A; Mini E; Cionini L; Ibrahim T; Amadori D; Del Tacca M
    Clin Pharmacol Ther; 2002 Dec; 72(6):627-37. PubMed ID: 12496744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic fibrosis does not affect the pharmacokinetics of 5-fluorouracil in rats.
    Nagata M; Hidaka Y; Hatakeyama K; Kawano Y; Iwakiri T; Okumura M; Arimori K
    Biopharm Drug Dispos; 2011 Mar; 32(2):126-30. PubMed ID: 21341281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept study.
    Capitain O; Asevoaia A; Boisdron-Celle M; Poirier AL; Morel A; Gamelin E
    Clin Colorectal Cancer; 2012 Dec; 11(4):263-7. PubMed ID: 22683364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
    Hoshino S; Yamashita Y; Maekawa T; Shirakusa T
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):648-52. PubMed ID: 15959779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients.
    Bocci G; Danesi R; Di Paolo AD; Innocenti F; Allegrini G; Falcone A; Melosi A; Battistoni M; Barsanti G; Conte PF; Del Tacca M
    Clin Cancer Res; 2000 Aug; 6(8):3032-7. PubMed ID: 10955781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
    Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
    Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A correlation study of fluorouracil pharmacodynamics with clinical efficacy and toxicity.
    Esin E; Telli TA; Yuce D; Yalcin S
    Tumori; 2018 Jun; 104(3):157-164. PubMed ID: 28708227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
    Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
    Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-ethyl-2'-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil.
    Kralovánszky J; Katona C; Jeney A; Pandi E; Noordhuis P; Erdélyi-Tóth V; Otvös L; Kovács P; Van der Wilt CL; Peters GJ
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):675-84. PubMed ID: 10592100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study.
    Kotake M; Imai H; Kaira K; Fujisawa T; Yanagita Y; Minato K
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):655-660. PubMed ID: 31250155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Percutanous trans-catheter intervention for the diagnosis and treatment of malignant pericardial effusion, with a report of 50 cases].
    Wu J; Liang S; Zhang Z
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):221-3. PubMed ID: 9387260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
    Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
    Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of 5-fluorouracil sustained-release particles in 81 malignant pericardial effusion patients.
    Ji YL; Li RZ; Xue LF; Li P; Liang XH; Dong L; Gao Y; Cui WC; Pang MX
    Kaohsiung J Med Sci; 2015 Feb; 31(2):96-101. PubMed ID: 25645988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 5-FU plasma concentration by 13C breath test in patients treated with oral 5-FU analogs.
    Higashida M; Matsumoto H; Kubota H; Murakami H; Kawabe Y; Nakashima H; Oka Y; Okumura H; Nakamura M; Hirai T
    Anticancer Res; 2012 Dec; 32(12):5407-14. PubMed ID: 23225444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors.
    Felici A; Loos WJ; Verweij J; Cirillo I; de Bruijn P; Nooter K; Mathijssen RH; de Jonge MJ
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):673-80. PubMed ID: 16544143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.